Cargando…
Plasma Globotriaosylsphingosine and α-Galactosidase A Activity as a Combined Screening Biomarker for Fabry Disease in a Large Japanese Cohort
Fabry disease is an X-linked disorder of α-galactosidase A (GLA) deficiency. Our previous interim analysis (1 July 2014 to 31 December 2015) revealed plasma globotriaosylsphingosine as a promising primary screening biomarker for Fabry disease probands. Herein, we report the final results, including...
Autores principales: | Maruyama, Hiroki, Taguchi, Atsumi, Mikame, Mariko, Izawa, Atsushi, Morito, Naoki, Izaki, Kazufumi, Seto, Toshiyuki, Onishi, Akifumi, Sugiyama, Hitoshi, Sakai, Norio, Yamabe, Kenji, Yokoyama, Yukio, Yamashita, Satoshi, Satoh, Hiroshi, Toyoda, Shigeru, Hosojima, Michihiro, Ito, Yumi, Tazawa, Ryushi, Ishii, Satoshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8928976/ https://www.ncbi.nlm.nih.gov/pubmed/34205365 http://dx.doi.org/10.3390/cimb43010032 |
Ejemplares similares
-
Distinctive accumulation of globotriaosylceramide and globotriaosylsphingosine in a mouse model of classic Fabry disease
por: Taguchi, Atsumi, et al.
Publicado: (2023) -
Plasma mutant α-galactosidase A protein and globotriaosylsphingosine level in Fabry disease
por: Tsukimura, Takahiro, et al.
Publicado: (2014) -
Globotriaosylsphingosine Accumulation and Not Alpha-Galactosidase-A Deficiency Causes Endothelial Dysfunction in Fabry Disease
por: Namdar, Mehdi, et al.
Publicado: (2012) -
Distributions of Globotriaosylceramide Isoforms, and Globotriaosylsphingosine and Its Analogues in an α-Galactosidase A Knockout Mouse, a Model of Fabry Disease
por: Sueoka, Hideaki, et al.
Publicado: (2015) -
Effectiveness of plasma lyso-Gb3 as a biomarker for selecting high-risk patients with Fabry disease from multispecialty clinics for genetic analysis
por: Maruyama, Hiroki, et al.
Publicado: (2018)